← Back to All Filings

Quest Diagnostics SVP Acquires Shares via DRIP Plan

Low SignificanceOctober 24, 2025 at 6:32:12 PM EDT

QUEST DIAGNOSTICS INC

$DGX4CIK: 0001022079

Subscribe to track DGX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Quest Diagnostics SVP Acquires Shares via DRIP Plan

Company: QUEST DIAGNOSTICS INC (DGX) Form: 4 | Filed: 2025-10-24 Significance: Low

Insider: KUPPUSAMY KARTHIK Title: SVP, Clinical Solutions | Relationship: Officer

Transaction: • Type: Acquisition (DRIP) • Shares: 15 • Price: $189.08 • Value: $2,836 • Owned After: 10,372 (Total Direct & Indirect)

Key Insight: This is a minor, routine acquisition of 15 shares through a dividend reinvestment plan (DRIP), as noted in the filing. It does not represent a significant insider sentiment shift.

Market Context: The transaction value is negligible (0.000014%) relative to Quest's $20.54B market capitalization.

Comprehensive Analysis

SEC Filing Analysis: QUEST DIAGNOSTICS INC (DGX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer acquired a nominal number of shares through a routine dividend reinvestment plan (DRIP), a transaction with no material significance.
  • Market Impact: Neutral. This type of transaction is automated and does not reflect a discretionary investment decision by the insider.

Company Information

FieldValue
CompanyQUEST DIAGNOSTICS INC
Ticker SymbolDGX
CIK0001022079
IndustryMedical Laboratories

Insider Information

FieldValue
NameKUPPUSAMY KARTHIK
CIK0001955217
Title/PositionSVP, Clinical Solutions
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-21
Transaction CodeA (Acquisition)
Security TypeCommon Stock
Shares Involved15
Price Per Share$189.076
Total Value$2,836.14
Shares Owned After8,379 (Directly)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$2,836.14
% of Market Cap0.000014%
Shares Transacted15
% of Shares Outstanding0.000013%
Post-Transaction Ownership10,372 shares (0.0093% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a $20.54 billion market cap, a transaction valued at approximately $2,800 is financially immaterial.
  • Ownership Concentration: The insider's total holdings of 10,372 shares represent a very small fraction (0.0093%) of the total shares outstanding, indicating low ownership concentration.
  • Dilution Impact: Not applicable, as this was an open-market acquisition via a DRIP, not an issuance of new shares.
  • Transaction Significance: The transaction is insignificant, representing less than 0.0001% of both market cap and shares outstanding. It is a passive investment action, not an active trading decision.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small to have any market impact. It is a non-discretionary acquisition resulting from a dividend reinvestment plan, which carries no informational value about the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: None. The trade size is negligible.
  • Sentiment Indicator: Neutral. This filing does not provide a bullish or bearish signal.

Investment Insights

Positive Market Indicators

  • None. This transaction is a routine, automated event.

Risk Factors

  • The primary risk is misinterpreting this routine filing as a meaningful insider purchase.

Key Takeaways

  1. Routine Transaction: The acquisition was made via a dividend reinvestment plan (DRIP), as disclosed in the filing's footnotes.
  2. Immaterial Value: The transaction's value of ~$2,836 is negligible compared to the company's $20.54B market cap.
  3. No Signal: This filing provides no new insight into insider confidence or company performance.

Additional Context

Transaction Notes

  • Special Circumstances: Footnote 1 explicitly states the shares were acquired via a dividend reinvestment plan. The insider chose to report this transaction, which is eligible for deferred reporting on Form 5, early on this Form 4.
Topics:#QuestDiagnostics#DGX#InsiderTrading#SECFiling#Form4#StockMarket#Investing#DRIP

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.